Literature DB >> 25696504

GIK in acute myocardial infarction: lessons from CREATE-ECLA, GIPS II and DIGAMI 2.

I C C van der Horst, F Zijlstra.   

Abstract

Entities:  

Year:  2005        PMID： 25696504      PMCID： PMC2497250     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  9 in total

1.  Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial.

Authors:  L Ceremuzyński; A Budaj; A Czepiel; T Burzykowski; P Achremczyk; W Smielak-Korombel; J Maciejewicz; J Dziubińska; E Nartowicz; T Kawka-Urbanek; W Piotrowski; J Hanzlik; A Cieśliński; K Kawecka-Jaszcz; J Gessek; K Wrabec
Journal:  Cardiovasc Drugs Ther       Date:  1999-05       Impact factor: 3.727

2.  Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report.

Authors:  D SODI-PALLARES; M R TESTELLI; B L FISHLEDER; A BISTENI; G A MEDRANO; C FRIEDLAND; A DE MICHELI
Journal:  Am J Cardiol       Date:  1962-02       Impact factor: 2.778

3.  Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions.

Authors:  F R Eberli; E O Weinberg; W N Grice; G L Horowitz; C S Apstein
Journal:  Circ Res       Date:  1991-02       Impact factor: 17.367

4.  Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group.

Authors:  R Díaz; E A Paolasso; L S Piegas; C D Tajer; M G Moreno; R Corvalán; J E Isea; G Romero
Journal:  Circulation       Date:  1998-11-24       Impact factor: 29.690

5.  Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon.

Authors:  L H Opie; K Bruyneel; P Owen
Journal:  Circulation       Date:  1975-07       Impact factor: 29.690

6.  Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials.

Authors:  F Fath-Ordoubadi; K J Beatt
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

7.  Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.

Authors:  Shamir R Mehta; Salim Yusuf; Rafael Díaz; Jun Zhu; Prem Pais; Denis Xavier; Ernesto Paolasso; Rashid Ahmed; Changchun Xie; Khawar Kazmi; Javed Tai; Andrés Orlandini; Janice Pogue; Lisheng Liu
Journal:  JAMA       Date:  2005-01-26       Impact factor: 56.272

8.  Glucose-insulin-potassium infusion in acute myocardial infarction. Review of clinical experience.

Authors:  C E Rackley; R O Russell; W J Rogers; J A Mantle; H G McDaniel
Journal:  Postgrad Med       Date:  1979-02       Impact factor: 3.840

9.  Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.

Authors:  K Malmberg; L Rydén; S Efendic; J Herlitz; P Nicol; A Waldenström; H Wedel; L Welin
Journal:  J Am Coll Cardiol       Date:  1995-07       Impact factor: 24.094
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.